Novel StAR Gene Mutation Identified in a Moroccan Patient with Lipoid Congenital Adrenal Hyperplasia by Hanane, Zaddouq et al.
19
Journal of Endocrinology Research | Volume 01 | Issue 02 | July 2019
Distributed under creative commons license 4.0 DOI: https://doi.org/10.30564/jer.v1i2.1149
Journal of Endocrinology Research
https://ojs.bilpublishing.com/index.php/jer
ARTICLE
Novel StAR Gene Mutation Identified in a Moroccan Patient with Li-
poid Congenital Adrenal Hyperplasia
Hanane Zaddouq1*   Althel Pharel Opoko²   Khadija Belhassan³   Intissar Haddiya4   
Ahmed Gaouzi¹
1. Endocrinology diabetology department, Rabat child Hospital, Rabat, Morocco
2. Endocrinology diabetology department, General Hospital of Loandjili, Pointe Noire, Republic of Congo
3. Hassan II University Medical Center- Genetic Department- Fes Medical School, 
4. Department of Nephrology, Faculty of medicine of Oujda, Morocco
ARTICLE INFO ABSTRACT
Article history
Received: 23 August 2019
Accepted: 11 November 2019
Published Online: 15 November 2019  
Congenital Adrenal Hyperplasia (CAH) is an autosomal recessive condi-
tion  that results from the deficiency of one of the steroidogenesis enzymes 
responsible for cortisol biosynthesis. In the majority of cases, CAH is 
caused by   21-hydroxylase deficiency. More rarely, the deficiency concerns 
11b-hydroxylase, 3b-hydroxysteroid dehydrogenase, 17hydroxylase, or 
exceptionally StAR and P450 oxydoreductase. Here, we report the case of 
a 3 year and 4 months old male child,  born from a consanguineous mar-
riage who presented at 15 months old with the salt-loss syndrome. Physical 
examination found generalized melanoderma, micropenis and bilateral 
cryptorchidism. Biological assessment at the time of diagnosis revealed 
hyponatremia, hyperkalemia, functional renal failure, hypoglycemia, low 
blood cortisol level, and high blood level of ACTH,  suggesting primary 
adrenal insufficiency. The patient presented  also with the abnormality of 
sexual differentiation with a 46 XY karyotype, testosteronemia level was 
low at the baseline and after HCG stimulation, pelvic ultrasound and Mag-
netic Raisonance Imaging (MRI) showed bilateral testicular atrophy in the 
inguinal position. The genetic study revealed a likely pathogenic homozy-
gous variant in the StAR (steroidogenic acute regulatory) gene. 
Therapeutically, our patient was hydrated by saline solution and treated 
with hydrocortisone and fludrocortisone, then benefited from a surgical tes-
ticular correction marked by a favorable evolution. Although mutations in 
StAR gene are rare, they can be responsible for the defect in the early stage 
of steroidogenesis and therefore cause a deficiency in adrenal and sexual 
hormones biosynthesis.
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1.Introduction
Congenital Adrenal Hyperplasia (CAH) is the re-sult of an adrenal enzymatic block.  Depending on the deficient enzyme, the biosynthesis of one 
or more hormones and sometimes an excess of synthesis 
of other hormones can occur. CAH is a genetic condition 
of autosomal recessive inheritance, commonly caused by 
21-hydroxylase enzymatic deficiency [1]. Steroidogenic 
acute regulatory deficiency (StAR) is responsible for a rare 
and severe form of CAH where its incidence in the gen-
eral population remains unknown. To date, only Eighty-
five cases from Japanese, Korean and Palestinian cohorts 
have been published in the literature [1]. Here, we report a 
patient with a defect in the adrenal and sexual hormones 
secondary to a mutation of the StAR gene highlighting the 
epidemiological, genetic, and phenotypic aspects of StAR 
gene mutations. 
2. Case Report
3 years and 4 months old boy, born to a family with first 
degree consanguineous marriage. His siblings do not pres-
ent any related health problem. The past medical history 
of his mother is marked with two incidents of spontaneous 
abortions.
Our patient was initially hospitalized at the age of 15 
months old for several episodes of acute dehydration 
aggravated by convulsive tonic-clonic seizures and com-
plicated by a coma. Physical examination in admission 
revealed  an acute dehydration associated with general-
ized melanoderma, micropenis, and bilateral cryptorchi-
dism (Figure1) Laboratory analysis revealed  a salt-loss 
syndrome with sodium levels of 113.1 mEq /l (139 mEql 
normal), high natriuresis to 112 mEq/l,potassium levels 
of 6.28 meq/l (3.5 – 5,2 mEq/l), a functional acute renal 
failure and hypoglycaemia at 0, 50 g/L, evoking primary 
adrenal insufficiency which was confirmed by a low level 
of 8 a.m. cortisol at 72 ng / ml (40-200 ng/l) and a high 
level of adrenocorticotropic hormone (ACTH) at 1250 μg 
/ ml (10.3- 48, 3 μg/ml). 
Other laboratory workup showed a low basal testos-
teronemia at 0.03 ng/ml then at 1.01ng / ml (0.03-0.32) 
after stimulation with Human Chorionic Gonadotropin 
Hormone (HCG). Noteworthy that this patient’s karyotype 
was normal with 46 XY. 
Pelvic ultrasound and pelvic MRI showed bilateral 
testicular atrophy in the inguinal position. This clinical 
presentation with double deficiency in adrenal and sex 
hormones, triggered after obtaining an  informed consent 
from parents a genetic study that revealed  the absence of 
mutations in  SF1 gene (steroidogenic factor 1) and DAX1 
gene (DSS-AHC critical area on the X chromosome, gene 
1) and the presence of a likely pathogenic homozygous 
variant in  the StAR gene.
The mutation was detected at position number 41 of the 
coding region of the gene with  transposition of Adenine 
to Cytosine c.41A> C resulting in a missense variant in 
the proteic sequence replacing Tyrosine with Serine. This 
variant p.Tyr14Ser affects a very conserved amino acid 
and In Silico predictive tools (SIFT, TASTER mutation 
and Polypen-2) confirmed its deleterious aspect (Figure 2).
Our patient was treated with intravenous hydrocorti-
sone, relayed by oral hydrocortisone at 30 mg/m2, after 
correction of acute dehydration, with progressive gradua-
tion at 15 mg /m2 per day, associated with fludrocortsione 
at 50 μg per day. Surgical treatment on the ascending tes-
ticle has been performed. The evolution was marked three 
years later by the appearance of right cervical lymphade-
nopathy with a positive tuberculin skin test > 20 mm ,and 
lymph node biopsy revealed tuberculous lymphadenitis 
with no histological sign of malignancy; for which the 
patient was put on antituberculosis treatment with a favor-
able evolution.
Figure 1. micropenis and absence of testicles in scrotal 
palpation
Figure 2. Pedigree presenting the genetic finding in the 
patient family 
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Haplotypes: 
a: Mutation c.41A>C or p.Tyr14Ser corresponding 
to exon 1 of StAR gene 
b: Normal* 
c: Normal* 
d: Mutation c.41A>C or p.Tyr14Ser corresponding 
to exon 1 of STAR gene
Note: * Normal: this chromosome does not carry mutations detected in 
the sick child.
Father: a-b
Mother: c-d
Sick child: a-d
Sister: b-c
Brother: not studied
3. Discussion 
Cholesterol is an important part of cellular membranes 
and is the substrate for biosynthesis of steroids, oxysterols 
and bile acids. Moreover , the mechanisms directing 
cholesterol trafficking inside cell gaived more attention 
through the discovery of the steroidogenic acute regulato-
ry protein StAR [1]. 
StAR is expressed in the adrenals and gonads, but not 
in the placenta.Congenital lipoid adrenal hyperplasia, a 
rare and severe disorder of human steroidogenesis, results 
from mutations in StAR, providing a StAR knockout of 
nature that has provided key insights into its activity. Cell 
biology experiments show that StAR moves large amounts 
of cholesterol from the outer to the inner mitochondrial 
membrane, but acts exclusively on the outer membrane [2].
Cholesterol will then be supported by the CYP11A1 
protein (P450scc) involved in the first stage of adrenal and 
testicular steroidogenesis.
3.1 The Role of STAR
StAR acts exclusively on the outer mitochondrial mem-
brane to bind cholesterol and is inactivated when imported 
into the mitochondria [3]. This process is important in the 
regulation of steroidogenesis. 
StAR gene mutations have now been described less 
than 200 patients with lipoid CAH, mostly from Japanese 
cohorts. In most studies the reported patients were sib-
lings, or they were born from consanguineous marriages 
[4]. The present study is the first one to identify the StAR 
Mutation c.41A>C   in a patient of Moroccan ancestry. 
Noteworthy, that in Moroccan patients the most frequent 
etiology of congenital adrenal hyperplasia is a 21-hydrox-
ylase deficiency.
StAR missense mutations causing lipoid CAH are 
mostly concentrated from exons 5–7. Whereas in our case 
it was located in the exon 1 .Deletion of only ten carbox-
yl-terminal amino acids reduces StAR activity by half, and 
deletion of only 28 carboxyl-terminal amino acids deletes 
all activity [5]. The small number of missense mutations 
that cause lipoid CAH all lie between amino acids 169 and 
275 [6]. In the absence of StAR expression, steroidogenic 
cells still produce 10–14% pregnenolone [1].
In general, mutations in the StAR gene usually lead to 
a classic form of the disease characterized by early onset 
adrenal insufficiency and gonadal failure, the latter show-
ing gender dimorphism both in severity and in time of 
onset. [7,8,9].
An attenuated form of the disease, “non-classic lipoid 
CAH,” is caused by mutations in which 10–25% of nor-
mal StAR activity is retained [6,10]. These patients typically 
experience adrenal insufficiency several years after in-
fancy and the 46,XY individuals may masculinize nor-
mally, and mineralocorticoid secretion may be minimally 
affected [11]. In our patient, a mutation of the StAR gene 
was detected in the homozygous state and confirmed by 
sequencing using the Sanger method and the family study. 
This c.41A> C or p.Tyr14Ser mutation affects a conserved 
amino acid up to C. elegans (12 species studied) and gives 
a serine amino acid with a very large chemical difference 
[Grantham distribution: 144 (0 - 215)]
As shown in the pedigree (Figure 2), both the father 
and the mother are healthy carriers of the mutation. The 
eldest daughter is mutation free, while our patient is ho-
mozygous for the mutation. The little brother and the rest 
of the family members were not explored. The association 
with tuberculous lymphadenitis would only be fortuitous 
since Morocco is a country of endemic tuberculosis, with 
an annual incidence of 92/100 000 [12].
3.2 Physiopathological of CAH due to StAR Mu-
tation
StAR promotes steroidogenesis by increasing the move-
ment of cholesterol into mitochondria, but in the absence 
of StAR, steroidogenic cells still make small amounts of 
steroids by StAR-independent steroidogenesis [3,6,13]. This 
observation led to the two-hit model of lipoid CAH [13] 
(Figure 3). 
Figure 3. Two-hit model of congenital lipoid adrenal 
hyperplasia (lipoid CAH) " image slightly modified from 
Himangshu SN Engl J Med 1996; 335:1870-1879"
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Note:
a. In normal adrenal cells, cholesterol is primarily derived from 
low-density lipoproteins, and the rate-limiting step in steroidogenesis is 
movement of cholesterol from the outer mitochondrial membrane (OMM) 
to the inner mitochondrial membrane (IMM). 
b. Early in lipoid CAH, StAR independent steroidogenesis moves small 
amounts of cholesterol into mitochondria, yielding sub-normal ste-
roidogenesis; adrenocorticotropic hormone (ACTH) secretion increases, 
stimulating further accumulation of cholesteryl esters in lipid droplets.
c. As lipids accumulate, they damage the cell through physical en-
gorgement and by the action of cholesterol auto-oxidation products; 
steroidogenic capacity is destroyed, but tropic stimulation continues. 
Ovarian follicular cells remain unstimulated and undamaged until pu-
berty, when small amounts of estradiol are produced, as in b, causing 
phenotypic feminization, with infertility and hypergonadotropic hypogo-
nadism [14].
This explains the phenotypic aspect of our patient and 
the delayed onset of symptoms until the age of 3 years 
and 4 months.
3.3 Diagnostic of CAH due to StAR Mutation
Lipoid CAH patients have normal external female 
genitalia either with XX or KY karyotype which makes it 
easy to differentiate them from XX patients with 21-hy-
droxylase deficiency who are virilized. In the other hand 
Lipoid CAH patients harbor low level of all steroid hor-
mones, while 21-hydroxylase deficient patients show high 
level of 21-deoxysteroids and 17-hydroxyprogesterone. 
Our patient with lipoid CAH also demonstrated low level 
17-hydroxyprogeterone of less than 0.3 ng/ml which ruled 
out the possibility of a 21 hydroxylase enzymatic block.
3b-hydrxysteroid dehydrogenase (3bHSD) deficiency 
caused by high level of 17-hydroxypregnenolone is a 
differential for lipoid CAH. In our case; and although the 
17-hydroxypregnenolone assay was not performed, the 
normal dehydroepiandrostendione sulfate (SDHEA) find-
ings excluded the diagnosis of 3bHSD deficiency.
The differentiation between lipoid CAH and congenital 
adrenal hypoplasia with a normal looking XY female gen-
italia is considered another clinical challenge that might 
be addressed by imaging; showing absent adrenal glands 
in congenital adrenal hypoplasia. 
4. Conclusion
In the Moroccan population, the high frequency of con-
sanguineous marriage uncovers several genetic conditions 
masked in the context of less consanguinity. Therefore, 
genetic screening should be recommended in high-risk 
families in order to decrease the occurrence of the genetic 
conditions and meanwhile prevents its complications that 
may be life-threatening. The present case report with acute 
adrenal insufficiency secondary to StAR gene mutation is 
an example of the critical importance of presymptomatic 
genetic diagnosis.
Declaration of interest
The authors declare that there is no conflict of interest.
References 
[1] Jasmeet Kaur , Luis Casas , and Himangshu S Bose. 
Lipoid congenital adrenal hyperplasia due to STAR 
mutations in a Caucasian patient. Endocrinology Di-
abetes &Metabolism Case Report, 2016. 
 DOI: 10.1530/EDM-15-0119  
[2] Walter L. Miller. Steroidogenic acute regulatory pro-
tein (StAR), a novel mitochondrial cholesterol trans-
porter. Biochimica et Biophysica Acta 1771, 2007: 
663–676. 
 DOI: 10.1016/j.bbalip.2007.02.012
[3] Bose, H.S., Lingappa, V.R. and Miller, W.L. Rapid 
regulation of steroidogenesis by mitochondrial pro-
tein import. Nature, 2002, 417: 87-91
[4] Carla Bizzarri1, Elisa Pisaneschi, Mafalda Muccio-
lo and al. Lipoid congenital adrenal hyperplasia by 
steroidogenic acute regulatory protein (STAR) gene 
mutation in an Italian infant:an uncommon cause of 
adrenal insufficiency, 2017.
 DOI: 10.1186/s13052-017-0371-y
[5] Bose HS. Mechanistic sequence of mitochondrial 
cholesterol transport by StAR proteins. Journal of 
Proteins and Proteomics, 2011, 2: 1–9.
[6] Miller WL & Bose HS. Early steps in steroidogen-
esis: intracellular cholesterol trafficking. Journal of 
Lipid Research, 2011, 52: 2111–2135. 
 DOI: 10.1194/jlr.R016675
[7] Bose HS, Sato S, Aisenberg J, Shalev SA, Matsuo N 
& Miller WL.Mutations in the steroidogenic acute reg-
ulatory protein (StAR) in six patients with congenital 
lipoid adrenal hyperplasia. Journal of Clinical Endocri-
nology and Metabolism, 2000, 85: 3636–3639.
 DOI: 10.1210/jc.85.10.3636
[8] Bose HS, Pescovitz OH & Miller WL. Spontaneous 
feminization in a 46,XX female patient with congen-
ital lipoid adrenal hyperplasia due to a homozygous 
frameshift mutation in the steroidogenic acute regu-
latory protein (StAR) gene. Journal of Clinical Endo-
crinology and Metabolism, 1997, 82: 1511–1515.
 DOI: 10.1210/jc.82.5.1511
[9] Fujieda K, Tajima T, Nakae J, Sageshima S, Tachi-
bana K, Suwa S,Sugawara T & Strauss JF III. Spon-
taneous puberty in 46,XX subjects with congenital 
lipoid adrenal hyperplasia. Ovarian steroidogenesis is 
spared to some extent despite inactivating mutations 
in the steroidogenic acute regulatory protein (StAR) 
gene. Journal of Clinical Investigation, 1997, 99: 
1265–1271.
DOI: https://doi.org/10.30564/jer.v1i2.1149
23
Journal of Endocrinology Research | Volume 01 | Issue 02 | July 2019
Distributed under creative commons license 4.0
 DOI: 10.1172/JCI119284
[10] Metherell LA, Naville D, Halaby G, Begeot M, 
Huebner A, Nu¨rnberg G,Nu¨rnberg P, Green J, Tom-
linson JW, Krone KP et al. Nonclassic lipoid con-
genital adrenal hyperplasia masquerading as familial 
glucocorticoid deficiency. Journal of Clinical Endo-
crinology and Metabolism, 2009, 94: 3865–3871.
 DOI: 10.1210/jc.2009-0467
[11] Miller WL & Auchus RJ. The molecular biology, 
biochemistry, and physiology of human steroidogen-
esis and its disorders. Endocrine Reviews, 2011, 32: 
81–151.
 DOI: 10.1210/er.2010-0013
[12] Association SOS tuberculose et maladies respira-
toires, 2012
[13] Bose HS, Sugawara T, Strauss JF 3rd, Miller WL. 
The pathophysiology and genetics of congenital li-
poid adrenal hyperplasia. N Engl J Med. 1996, 335: 
1870–8.
[14] Barbara J. Clark • Douglas M. Stocco. Cholesterol 
Transporters of the START Domain Protein Family 
in Health and Disease. Springer New York Heidel-
berg Dordrecht London, 2014.
 DOI: 10.1007/978-1-4939-1112-7
DOI: https://doi.org/10.30564/jer.v1i2.1149
